Cancer Immunotherapy Drug Discovery Outsourcing Market contains market size and forecasts of Cancer Immunotherapy Drug Discovery Outsourcing in Global, including the following market information:
- Global Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Cancer Immunotherapy Drug Discovery Outsourcing market was valued at 1027.7 million in 2021 and is projected to reach US$ 2031 million by 2028, at a CAGR of 10.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
By Drug Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Immunotherapy Drug Discovery Outsourcing include Aquila BioMedical, BPS Bioscience, Inc., Celentyx Ltd, Crown Bioscience, Inc., DiscoverX Corporation, Explicyte, Genscript Biotech Corporation, HD Biosciences Co. and Horizon Discovery Group PLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Immunotherapy Drug Discovery Outsourcing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment Percentages, by Type, 2021 (%)
- By Drug Type
- By Cancer Type
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment Percentages, by Application, 2021 (%)
- Lung
- Breast
- Colorectal
- Melanoma
- Prostate
- Head and Neck
- Ovarian
- Pancreatic
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cancer Immunotherapy Drug Discovery Outsourcing revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Cancer Immunotherapy Drug Discovery Outsourcing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Aquila BioMedical
- BPS Bioscience, Inc.
- Celentyx Ltd
- Crown Bioscience, Inc.
- DiscoverX Corporation
- Explicyte
- Genscript Biotech Corporation
- HD Biosciences Co.
- Horizon Discovery Group PLC
- ImmunXperts SA
- Molecular Imaging, Inc.
- Promega Corporation,Personalis, Inc.
- STC Biologics
Industry Market Size
